Company: ANY
Filing Date: 2025-01-03
Form Type: 424B5
Source: 0001062993-25-000228
Chunk: 11

Company: Sphere 3D Corp.
Filing Date: 2025-01-03
Form: 424B5
Chunk 11
---
 common shares in this offering will be approximately $7.7 million after deducting the Sales Agent fees, discounts and commissions and estimated offering expenses payable by us.

We currently intend to use the net proceeds from this offering primarily for working capital and general corporate purposes and in furtherance of our corporate strategy which may include to accelerate efficiency, for the purchase/upgrade of our mining fleet, and vertical integration of infrastructure. We have not entered into any definitive agreements with respect to any acquisitions as of the date of this prospectus supplement. Pending application of the net proceeds as described above, we may invest the net proceeds of this offering in short-term, investment-grade, interest-bearing securities.

We have broad discretion in determining how the proceeds of this offering will be used, and our discretion is not limited by the aforementioned possible uses. Our board of directors believes the flexibility in application of the net proceeds is prudent. See the section entitled "Risk Factors-Risks Relating to this Offering- Management will have broad discretion as to the use of the proceeds from this offering, and we may not use the proceeds effectively ."

<div align='center'>PS-7

CAPITALIZATION</div>

The following table sets forth our cash and cash equivalents and capitalization as of September 30, 2024:

| ● | on an actual basis; and |

| ● | on an as adjusted basis after giving effect to the equity issuances and financings between September 30, 2024 and January 3, 2025 in the aggregate amount of approximately $10.3 million and the sale of our common shares pursuant to this prospectus supplement in the aggregate amount of approximately $7.7 million, assuming the sale of all of the shares offered hereunder at an assumed offering price of $1.01 per share, the last reported sale price of our common shares on the Nasdaq Capital Market on January 2, 2025, and after deducting commissions and estimated aggregate offering expenses payable by us. |

You should read this table together with the section of this prospectus titled "Use of Proceeds," as well as our consolidated financial statements and the related notes and the sections titled "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2023 and our Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2024, June 30, 2024 and September 30, 2024, each of which